Drug Approval Package
-
Exelon
(Rivastigmine Tartrate) Capsules
Company: Novartis Pharmaceuticals Corporation
Application No.: 20-823
Approval Date: 4/21/2000
-
Approval Letter(s)(PDF)
-
Printed Labeling(PDF)
-
Chemistry Review(s)
Part 1(PDF) Part 6(PDF) Part 2(PDF) Part 7(PDF) Part 3(PDF) Part 8(PDF) Part 4(PDF) Part 9(PDF) Part 5(PDF) Part 10(PDF)
Date created: October 11, 2001
Note: Documents in PDF format require the Adobe Acrobat Reader®.
-